IDRC News & Events
CDC-CSU Team Wins Governor’s Award for Research
A team of researchers from the Centers for Disease Control and Prevention and Colorado State University was recognized with one of the 2018 CO-LABS Governor’s Awards…
IDRC Publishes October 2018 Newsletter
Beginning in spring 2019, up to 6 graduate students can enroll in a 5-6 week BioMARC internship class. Students will take a mock ‘product’ through the manufacturing process, getting exposure to all aspects…
VeriPrime to Join Research Innovation Center
VeriPrime is very pleased to announce that as of September 1, 2018, the VeriPrime Research Division and VeriPrime Livestock Production Physiology Laboratory will take residence in the Research Innovation Center…
RIC Tenant Prieto Battery Featured in Chemical & Engineering News
Amy Prieto decided to pursue battery research when she started as an assistant professor of chemistry at Colorado State University in 2005. The field was a perfect bridge…
IDRC Publishes June 2018 Newsletter
BioMARC has won a large new contract for the scale-up and manufacturing process development of an innovative new vaccine candidate for Salmonella typhi and Salmonella paratyphi developed by researchers…
BioMARC Wins Typhoid Vaccine Manufacturing Project for Boston Children’s Hospital June 2018
BioMARC, the Biopharmaceutical Manufacturing and Academic Resource Center, a non-profit biologics contract development and manufacturing organization (CDMO), owned and operated by Colorado State University…
RIC Tenant Vivaldi Biosciences in the News for Universal Flu Vaccine Progress
Colorado State-based researchers push closer to universal flu vaccine … Aspelund and her team at Vivaldi Biosciences, a company based at the … With that method, Aspelund and her team can develop a new vaccine in…
IDRC Publishes March 2018 Newsletter
BioMARC has won a large new contract to scale up the manufacturing process for an innovative new HIV vaccine candidate being developed by Seoul, South Korea based biotechnology company Sumagen Co, Ltd. The key task of this new contract is to continue…
BioMARC Wins HIV Manufacturing Project– March 2018
BioMARC, a non-profit biologics contract development and manufacturing organization (CDMO) owned and operated by Colorado State University (CSU), has won a large new contract with Sumagen Co., Ltd, a Seoul…
RIC Tenant Vivaldi Biosciences Reports Breakthrough Results for Influenza Vaccine Cross Protection
Vivaldi Biosciences, based at the Research Innovation Center at Colorado State University and Vienna, Austria, today announced that its deltaFLU influenza vaccine…
Dr. John Wyckoff Joins BioMARC as Director
John Wyckoff has been named the new director of the Biopharmaceutical Manufacturing and Academic Resource Center (BioMARC) at Colorado State University. Wyckoff will lead BioMARC, a nonprofit contract manufacturing operation owned and operated by CSU to produce…
CSU Researchers Develop New Lyme Disease Test
Lyme disease is the most commonly reported vector-borne illness in the United States, but it can be confused with similar conditions, including Southern Tick-Associated Rash Illness (STARI). A team of researchers led by Colorado State University …
IDRC Hosts Symposium on Innovation in Infectious Disease Research
Infectious disease research continues to be an area of prominence in addressing public health care concerns. More than 1,400 species of human pathogens are reported in the literature, and of those 58% are known to be zoonotic…
CSU works with CDC to help public health labs detect Zika Virus
Since the Zika virus was first reported in Florida and Texas, Colorado State University has been researching the virus and working to help improve how states across the country test for viruses carried by mosquitoes…